Rapport Therapeutics (RAPP) Interest & Investment Income (2023 - 2026)
Rapport Therapeutics (RAPP) posted Interest & Investment Income of $4.19 million for Q2 2026, up 51.6% from $2.76 million a year earlier but down 3.8% from the prior quarter.
Powered by 
Analysis
Rapport Therapeutics (RAPP) Interest & Investment Income (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Rapport Therapeutics was $16.36 million, up 21.6% year-over-year; for FY2025, it came in at $13.62 million, up 12.2% from FY2024.
- In prior years, Rapport Therapeutics' Interest & Investment Income was $12.14 million in FY2024 (+380.3%) and $2.53 million in FY2023.
- Quarterly Interest & Investment Income has run from a low of $221,000 in Q2 2023 to a high of $4.75 million in Q4 2025 over five years.
- On a year-over-year basis, Interest & Investment Income has increased in each of the last three quarters, with growth averaging 88.9% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q3 2024, with growth of 379.3%; the weakest was Q3 2025, with a decline of 25.4%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $4.36 million (Q1 2026), $4.75 million (Q4 2025) and $3.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Rapport Therapeutics | 1.54 Bn | 1.54 Bn | - | 4.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.19 Mn |
| Mar 31, 2026 | 4.36 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 2.68 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 856,000.00 |
| Jun 30, 2023 | 221,000.00 |
API Access
Rapport Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RAPP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "RAPP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RAPP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();